Home > Balance Sheet > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹1,565 Cr₹1,398 Cr₹729 Cr₹582 Cr₹513 Cr

What is the latest Total Current Liabilities ratio of GLAND PHARMA ?

The latest Total Current Liabilities ratio of GLAND PHARMA is ₹1,565 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹1,565 Cr
Mar2024₹1,398 Cr
Mar2023₹729 Cr
Mar2022₹582 Cr
Mar2021₹513 Cr

How is Total Current Liabilities of GLAND PHARMA Trending?

Years Total Current Liabilities % Change
Mar2025 ₹1,565 Cr
11.91
Mar2024 ₹1,398 Cr
91.78
Mar2023 ₹729 Cr
25.28
Mar2022 ₹582 Cr
13.56
Mar2021 ₹513 Cr -

Compare Total Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹30,010.1 Cr 0.7% 5.8% 26% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.7%

5.8%

26%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses